n/a
Article Publish Status: FREE
Abstract Title:

Resveratrol inhibits the proliferation of A549 cells by inhibiting the expression of.

Abstract Source:

Onco Targets Ther. 2018 ;11:2981-2989. Epub 2018 May 22. PMID: 29872310

Abstract Author(s):

Xia Li, Fang Li, Fangfang Wang, Jinfeng Li, Cunzhi Lin, Jianxin Du

Article Affiliation:

Xia Li

Abstract:

Purpose: The aim was to investigate resveratrol effects on A549 cells proliferation.

Methods: A total of 104 lung adenocarcinoma tissues and nontumor tissues were collected. BEAS-2B cells were cultured in RPMI 1640 medium (group A). A549 cells were treated with RPMI 1640 medium containing different resveratrol concentrations. A549 cells were transfected and grouped as follows: blank group, siRNA-negative control group, siRNA-COX-2 group and resveratrol + siRNA-COX-2 group. qRT-PCR and Western blot were conducted to detectexpression. MTT assay, soft agar clone assay and flow cytometry were performed to assess proliferation and cell cycle.

Results: The relative expression ofmRNA was significantly increased in lung adenocarcinoma tissues (<0.01) and it was closely related with clinical stages. Resveratrol at 60μmol/L significantly inhibited A549 cells proliferation, S phase cells proportion andexpression (<0.01). COX-2 expression in siRNA-COX-2 group was significantly lower than that in blank group and siRNA-negative control group (<0.01). ODvalues, colony formation rate and S phase cells proportion of resveratrol + siRNA-COX-2 group were much lower than those of other groups (<0.01).

Conclusion: Resveratrol inhibits A549 cells proliferation by inhibitingexpression.

Study Type : In Vitro Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.